• contact
  • home
  • about
    • our history
    • management
    • board of directors
    • advisors
  • approach
  • pipeline
  • news & insights
    • presentations
    • press releases
    • references (PRL-02)
    • references (CGS-200-5)
  • careers
  • contact
  • Menu

Well-Tolerated Topical Capsaicin Formulation Reduces Knee OA Pain

/in references (CGS-200-5) /by neil

News coverage of our CGS-200-5 Phase 2 results for OA pain of the knee.

Read Article

https://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svg 0 0 neil https://propellatx.com/wp-content/uploads/2020/04/Propella-logo-horz.svg neil2019-12-18 17:49:002021-09-09 15:32:26Well-Tolerated Topical Capsaicin Formulation Reduces Knee OA Pain

categories

  • presentations
  • press releases
  • references (CGS-200-5)
  • references (PRL-02)
  • home
  • about
  • approach
  • pipeline
  • news & insights
  • careers
  • contact
© 2020-2023 Propella Therapeutics, Inc. / all rights reserved
  • privacy policy
  • terms of use
  • copyright policy
Presentation at the Annual Meeting of the American College of Rheumatology (November... Press Release: New Osteoarthritis (OA) Treatment Guidelines Issued … Expert...
Scroll to top